focus -WSS

focus

author：entertainment 2025-09-07 11:16:26 - browse：15

Have you ever taken phenylephrine for a stuffed-up nose and then felt better? If so, you might have been perplexed when Food and Drug Administration experts recently said that that the drug — which is in some versions of DayQuil, Sudafed, and other medicines — is no more effective than a placebo.

But to Michael H. Bernstein, an assistant professor of diagnostic imaging at the Warren Alpert Medical School of Brown University, it all makes sense. Bernstein says that “no better than a placebo” still means that it works, sort of. “If we expect to feel better, then we probably will,” he told me. And that complicates the idea of what medical treatment “works.”

On this episode of the “First Opinion Podcast,” we discuss the placebo effect and its counterpart, the “nocebo effect” — if you tell patients something will make them feel worse, it generally comes true. “You’re better off hearing from a doctor something to the effect of 3 out of 4 patients who take this drug have no side effects at all versus 25% of people who take this drug do get side effects,” he said.

Bernstein also shared the delightful story of how he got into the “medical expectations” field, which started with an experiment in which he had to convince underage students that they were drinking alcohol when they weren’t.

Our conversation was based on a First Opinion Bernstein recently wrote with Grayson L. Baird, “Phenylephrine is no better than a placebo. What if that’s still better than nothing?”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Should insurance cover cosmetic surgery?

Wikipedia

WSS

AI can’t replace a physician’s gut feeling

At Orexo, a ‘turning point’ for everything but digital health

Cosmetics set for new safety regulation. Why the industry is on board

Custom gene therapy hints at new path for rare disease treatments

Medicare has a new plan to address drug shortages

Louisiana bill approved classifying abortion pills as controlled substances

explore

focus

entertainment

Guidelines to prevent youth baseball injuries need more muscle

AI can’t replace a physician’s gut feeling

Guidelines to prevent youth baseball injuries need more muscle

Sanders adds drug shortage policies to pandemic preparedness bill

Continuity nursing helped my family in our darkest PICU moments

Unmasking the 'centricity' illusion in clinical trials

Supreme Court strikes down use of affirmative action

Stroke rates rising, especially in working

Medical leaders decry Supreme Court decision on affirmative action

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

focus

Medicare to cover more brain scans for Alzheimer’s patients

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Group opposing PBM reform sets lobbying record

Medicare has a new plan to address drug shortages

Pharma’s losing bet in New Jersey

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Wikipedia

Wikipedia

Wikipedia

focus